These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. ABCD1 deletion-induced mitochondrial dysfunction is corrected by SAHA: implication for adrenoleukodystrophy. Baarine M, Beeson C, Singh A, Singh I. J Neurochem; 2015 May; 133(3):380-96. PubMed ID: 25393703 [Abstract] [Full Text] [Related]
5. Impaired very long-chain acyl-CoA β-oxidation in human X-linked adrenoleukodystrophy fibroblasts is a direct consequence of ABCD1 transporter dysfunction. Wiesinger C, Kunze M, Regelsberger G, Forss-Petter S, Berger J. J Biol Chem; 2013 Jun 28; 288(26):19269-79. PubMed ID: 23671276 [Abstract] [Full Text] [Related]
6. Silencing of Abcd1 and Abcd2 genes sensitizes astrocytes for inflammation: implication for X-adrenoleukodystrophy. Singh J, Khan M, Singh I. J Lipid Res; 2009 Jan 28; 50(1):135-47. PubMed ID: 18723473 [Abstract] [Full Text] [Related]
8. The role of ELOVL1 in very long-chain fatty acid homeostasis and X-linked adrenoleukodystrophy. Ofman R, Dijkstra IM, van Roermund CW, Burger N, Turkenburg M, van Cruchten A, van Engen CE, Wanders RJ, Kemp S. EMBO Mol Med; 2010 Mar 28; 2(3):90-7. PubMed ID: 20166112 [Abstract] [Full Text] [Related]
14. Cholesterol regulates ABCD2 expression: implications for the therapy of X-linked adrenoleukodystrophy. Weinhofer I, Forss-Petter S, Zigman M, Berger J. Hum Mol Genet; 2002 Oct 15; 11(22):2701-8. PubMed ID: 12374760 [Abstract] [Full Text] [Related]